Michela Rondoni
8PUBLICATIONS
69CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 05, 2025
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.Raffaele Palmieri, Fabio Guolo, Luana Fianchi
|Jul 29, 2025
Acute Myeloid Leukemia: Updates on Diagnosis, Treatment and Management.Francesco Lanza, Michela Rondoni, Giovanni Marconi
|Apr 14, 2025
Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype.Michela Rondoni, Giovanni Marconi, Annalisa Nicoletti
|Mar 06, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio
|Oct 25, 2024
Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS.Thomas Cluzeau, Fabio Guolo, Edmond Chiche
|Jul 14, 2023
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience.Luana Fianchi, Fabio Guolo, Francesco Marchesi
Pageof 2
Frequent Collaborators
5 joint publications
Fabio Guolo
3 joint publications
Francesco Lanza
3 joint publications
Francesco Grimaldi
3 joint publications
Adriano Venditti
3 joint publications
Paola Minetto
3 joint publications
Marco Cerrano
3 joint publications
Cristina Papayannidis
3 joint publications
Livio Pagano
3 joint publications
Patrizia Chiusolo
2 joint publications
Chiara Cattaneo
